Alivus Life Sciences Invests Rs 14.04 Crore in Renewable SPV

• Investment: Rs 14.04 Crore for a 9.21% stake.
• Commitment: Total capital outlay up to Rs 16 crore.

Reader Takeaway: The investment secures captive power status to drive green energy adoption and long-term carbon neutrality goals.

What just happened

Alivus Life Sciences Limited has acquired a 9.21% equity stake in Torrent Urja 19 Private Limited. This entity acts as a special purpose vehicle (SPV) established by Torrent Green Energy Private Limited to develop renewable energy projects. Alivus has invested Rs 14.04 crore in cash for this stake and maintains a maximum investment commitment of Rs 16 crore.

Why this matters

The primary objective of this acquisition is to fulfill the company’s strategic commitment to achieve carbon neutrality by 2030. By investing in this SPV, Alivus gains the status of a 'captive user' as defined under the Electricity Act, 2003. This regulatory classification allows the company to source a higher proportion of its energy requirements from renewable solar power, which helps in managing long-term power costs and improving operational sustainability.

Target Entity Profile

Torrent Urja 19 Private Limited was incorporated on August 6, 2024. Its core business is the generation, transmission, and distribution of electrical power via solar and other renewable sources. As of the latest reporting, the entity is in its nascent stage with a nil turnover history.

Risks to watch

As the SPV is in the early stages of its lifecycle, the realization of benefits depends entirely on the successful commissioning and operational efficiency of the renewable power projects. Investors should watch for project delays or regulatory changes that could impact the 'captive user' benefits.

Context

While the acquisition is not classified as a related party transaction for Alivus, the company noted that its promoter, Nirma Limited, has made a parallel investment in the same SPV, currently holding a 16.99% stake.